# OnCo record krishnansu-tewari (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/krishnansu-tewari/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "krishnansu-tewari" ;
  schema:name "Krishnansu S. Tewari"@en ;
  schema:description "California gynaecologic oncologist who led GOG 240, the trial that made bevacizumab the first targeted drug to lengthen survival in advanced cervical cancer, and EMPOWER-Cervical 1, which did the same for the PD-1 antibody cemiplimab."@en ;
  schema:url <https://onco.cc/people/krishnansu-tewari/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "cervical", "gynaecological", "trialist" ;
  schema:jobTitle "Gynaecologic oncologist, Chao Family Comprehensive Cancer Center, UC Irvine" ;
  onco:cancers <https://onco.cc/cancers/recurrent-metastatic-cervical-cancer/>, <https://onco.cc/cancers/cervical/> ;
  onco:institutions <https://onco.cc/institutions/uci-chao/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-empower-cervical-1-cemiplimab-nejm-2022/>, <https://onco.cc/key-papers/paper-gog-240-bevacizumab-cervical-nejm-2014/> ;
  schema:affiliation <https://onco.cc/institutions/uci-chao/> .